Working… Menu

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (GBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00045968
Recruitment Status : Unknown
Verified October 2016 by Northwest Biotherapeutics.
Recruitment status was:  Active, not recruiting
First Posted : September 19, 2002
Last Update Posted : October 14, 2016
Information provided by (Responsible Party):
Northwest Biotherapeutics

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2016
Study Completion Date : No date given